Charles River Laboratories International (CRL) Operating Expenses (2009 - 2026)

Charles River Laboratories International has reported Operating Expenses for 18 years, with the latest figure at $228.9 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 19.5% year-over-year to $228.9 million in Q2 2026; TTM through Jun 2026 was $762.0 million, a 0.29% change from a year earlier, with the FY2025 full-year figure at $743.1 million, down 1.06% from the prior year.
• Operating Expenses was $228.9 million for Q2 2026 at Charles River Laboratories International, up from $159.4 million in the prior quarter.
• The five-year high for Operating Expenses was $228.9 million in Q2 2026, with the low at $131.7 million in Q2 2022.
• Average Operating Expenses over 5 years is $183.1 million, with a median of $185.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses decreased 23.2% in 2022, then surged 51.66% in 2023.
• Over 5 years, Operating Expenses stood at $199.6 million in 2022, then fell by 1.25% to $197.1 million in 2023, then dropped by 0.73% to $195.7 million in 2024, then increased by 0.22% to $196.1 million in 2025, then advanced by 16.7% to $228.9 million in 2026.
• The last three Operating Expenses figures came in at $228.9 million (Q2 2026), $159.4 million (Q1 2026), and $196.1 million (Q4 2025), per Business Quant data.